Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;64(1):413-21.
doi: 10.1016/j.cyto.2013.05.006. Epub 2013 May 30.

Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours

A Browne  1 , R Sriraksa, T Guney, N Rama, S Van Noorden, E Curry, H Gabra, E Stronach, M El-Bahrawy
Affiliations

Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours

A Browne et al. Cytokine. 2013 Oct.

Abstract

Introduction: Ovarian Cancer is the leading cause of death from gynecological malignancy. The poor prognosis is mainly due to presentation at a late stage and poor response to therapy. Much research is needed to identify diagnostic and prognostic biomarkers as well as therapeutic targets for ovarian cancer. Interleukin-8 is expressed by many tumour types and is known to have mitogenic, motogenic and angiogenic effects on tumour cells.

Aims: The aim of this study was to investigate the expression of IL-8 and IL-8 receptors (IL-8RA and IL-8RB) in different histological subtypes of ovarian tumours, as potential prognostic biomarkers in ovarian tumours.

Materials and methods: Immunohitochemistry was used to study the expression of IL-8 and IL-8 receptors in 115 ovarian tumours including 21 benign tumours, 25 borderline tumours and 69 carcinomas of serous, clear cell, endometrioid and mucinous types. The correlation of expression profile, tumour type, stage, and progression free survival and overall survival was statistically analysed.

Results: IL-8 and IL-8 receptors were expressed in all types of tumours with variable intensity and subcellular distribution. There was a statistically significant correlation between levels of expression and tumour stage and tumour type, being mostly significant in serous tumours. No correlation with patient progression free survival or overall survival was found.

Conclusion: This is the first study investigating the expression of IL-8 and IL-8 receptors using immunohistochemistry in different types of ovarian tumours, including benign and borderline tumours. IL-8 and IL-8RA are potential prognostic biomarkers and therapeutic targets in ovarian cancer, particularly in ovarian serous carcinoma.

Keywords: Biomarkers; CCC; EC; IL-8; Interleukin-8; Interleukin-8 receptors; MC; OVCA; Ovarian; SC; Tumours; clear cell carcinoma; endometrial carcinoma; interleukin-8; mucinous carcinoma; ovarian carcinoma; serous carcinoma.

PubMed Disclaimer

Publication types

MeSH terms